News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
778,887 Results
Type
Article (70640)
Company Profile (641)
Press Release (707606)
Multimedia
Podcasts (110)
Webinars (14)
Section
Business (220432)
Career Advice (2922)
Deals (38069)
Drug Delivery (120)
Drug Development (86651)
Employer Resources (182)
FDA (17222)
Job Trends (16509)
News (372570)
Policy (34991)
Tag
Academia (2904)
Academic (2)
Accelerated approval (5)
Adcomms (20)
Allergies (93)
Alliances (54930)
ALS (99)
Alzheimer's disease (1494)
Antibody-drug conjugate (ADC) (152)
Approvals (17195)
Artificial intelligence (291)
Autoimmune disease (28)
Automation (15)
Bankruptcy (389)
Best Places to Work (12293)
BIOSECURE Act (22)
Biosimilars (114)
Biotechnology (439)
Bladder cancer (82)
Brain cancer (31)
Breast cancer (295)
Cancer (2397)
Cardiovascular disease (197)
Career advice (2457)
Career pathing (34)
CAR-T (170)
Cell therapy (478)
Cervical cancer (21)
Clinical research (69854)
Collaboration (907)
Compensation (546)
Complete response letters (30)
COVID-19 (2815)
CRISPR (46)
C-suite (265)
Cystic fibrosis (106)
Data (2262)
Decentralized trials (2)
Denatured (39)
Depression (54)
Diabetes (290)
Diagnostics (6825)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (133)
Drug pricing (118)
Drug shortages (30)
Duchenne muscular dystrophy (100)
Earnings (89767)
Editorial (44)
Employer branding (24)
Employer resources (158)
Events (122511)
Executive appointments (772)
FDA (18521)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (808)
Gene editing (116)
Generative AI (29)
Gene therapy (345)
GLP-1 (827)
Government (4491)
Grass and pollen (6)
Guidances (65)
Healthcare (19987)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (142)
Indications (30)
Infectious disease (2971)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (55)
Intellectual property (100)
Interviews (546)
IPO (17517)
IRA (49)
Job creations (4708)
Job search strategy (2058)
Kidney cancer (11)
Labor market (36)
Layoffs (549)
Leadership (24)
Legal (8710)
Liver cancer (80)
Lung cancer (338)
Lymphoma (157)
Machine learning (7)
Management (63)
Manufacturing (341)
MASH (73)
Medical device (14414)
Medtech (14419)
Mergers & acquisitions (21100)
Metabolic disorders (763)
Multiple sclerosis (87)
NASH (20)
Neurodegenerative disease (113)
Neuropsychiatric disorders (33)
Neuroscience (2098)
NextGen: Class of 2025 (7211)
Non-profit (4759)
Now hiring (40)
Obesity (408)
Opinion (271)
Ovarian cancer (78)
Pain (99)
Pancreatic cancer (86)
Parkinson's disease (160)
Partnered (23)
Patents (249)
Patient recruitment (116)
Peanut (51)
People (62964)
Pharmaceutical (132)
Pharmacy benefit managers (18)
Phase I (21735)
Phase II (30578)
Phase III (22972)
Pipeline (1250)
Policy (156)
Postmarket research (2964)
Preclinical (9738)
Press Release (72)
Prostate cancer (112)
Psychedelics (37)
Radiopharmaceuticals (268)
Rare diseases (418)
Real estate (6836)
Recruiting (73)
Regulatory (24031)
Reports (40)
Research institute (2642)
Resumes & cover letters (443)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (91)
Service/supplier (27)
Sickle cell disease (56)
Special edition (17)
Spinal muscular atrophy (163)
Sponsored (34)
Startups (4133)
State (2)
Stomach cancer (15)
Supply chain (74)
Tariffs (43)
The Weekly (69)
Vaccines (789)
Venture capitalists (44)
Weight loss (288)
Women's health (37)
Worklife (20)
Date
Today (211)
Last 7 days (938)
Last 30 days (2801)
Last 365 days (35044)
2025 (11403)
2024 (37578)
2023 (42323)
2022 (53680)
2021 (58226)
2020 (56789)
2019 (49671)
2018 (37823)
2017 (35857)
2016 (36206)
2015 (42507)
2014 (36594)
2013 (32657)
2012 (33688)
2011 (33713)
2010 (32157)
Location
Africa (1023)
Alabama (60)
Alaska (7)
Arizona (223)
Arkansas (14)
Asia (47526)
Australia (8119)
California (6398)
Canada (2053)
China (560)
Colorado (279)
Connecticut (300)
Delaware (157)
Europe (105670)
Florida (934)
Georgia (215)
Hawaii (1)
Idaho (62)
Illinois (582)
India (30)
Indiana (329)
Iowa (12)
Japan (169)
Kansas (110)
Kentucky (28)
Louisiana (13)
Maine (69)
Maryland (936)
Massachusetts (4924)
Michigan (241)
Minnesota (418)
Mississippi (2)
Missouri (92)
Montana (30)
Nebraska (26)
Nevada (63)
New Hampshire (70)
New Jersey (1814)
New Mexico (31)
New York (1821)
North Carolina (1112)
North Dakota (8)
Northern California (2740)
Ohio (219)
Oklahoma (14)
Oregon (46)
Pennsylvania (1412)
Puerto Rico (13)
Rhode Island (36)
South America (1401)
South Carolina (24)
South Dakota (1)
Southern California (2364)
Tennessee (103)
Texas (945)
United States (24457)
Utah (189)
Virginia (167)
Washington D.C. (67)
Washington State (597)
West Virginia (3)
Wisconsin (66)
778,887 Results for "yeda research and development company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine
April 28, 2025
·
3 min read
Press Releases
Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
April 14, 2025
·
8 min read
Opinion
AI Enables Companies to Break From the Herd in Drug Development
Researchers in pharma and beyond have historically glommed onto a limited number of disease targets, limiting innovation. AI could change that.
April 7, 2025
·
6 min read
·
Ruth Gross
Bio NC
CoImmune, Inc. Announces Research Collaboration with Yeda Research and Development Company Ltd.
CoImmune, Inc. announced a research collaboration with Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science, to evaluate the applications of the Synthetic Immune Niche technology, developed by Weizmann Institute’s researchers to enhance the expansion and function of human cytokine induced killer cells expressing chimeric antigen receptors.
November 17, 2021
·
3 min read
Press Releases
ATED Therapeutics, Ltd.: New Rapid, Simple Blood Test for Parkinson’s Disease Developed
April 14, 2025
·
2 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Press Releases
Transneural Therapeutics Appoints CNS Drug Development Expert, Mark A. Demitrack, MD, as Chief Research and Development Officer
April 29, 2025
·
3 min read
Press Releases
SMSbiotech Establishes a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Chemical Defense
April 22, 2025
·
1 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
Press Releases
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
April 16, 2025
·
5 min read
1 of 77,889
Next
